Rodrigues Filipe B, Wild Edward J
Huntington's Disease Centre, University College London, UK.
Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Portugal.
J Huntingtons Dis. 2018;7(1):89-98. doi: 10.3233/JHD-189001.
In the second edition of the Huntington’s Disease Clinical Trials Corner we list all currently registered and ongoing clinical trials, summarise the top-line results of the recently-announced IONIS-HTTRX trial (NCT02519036), expand on Wave Life Sciences’ PRECISION-HD1 (NCT03225833) and PRECISION-HD2 (NCT03225846), and cover one recently finished trial: the FIRST-HD deutetrabenazine trial (NCT01795859).
在《亨廷顿舞蹈症临床试验角》第二版中，我们列出了所有当前注册并正在进行的临床试验，总结了最近公布的IONIS-HTTRX试验（NCT02519036）的主要结果，详细介绍了Wave生命科学公司的PRECISION-HD1（NCT03225833）和PRECISION-HD2（NCT03225846），并涵盖了一项最近完成的试验：FIRST-HD氘代丁苯那嗪试验（NCT01795859）。
